Equities

Medical Developments International Ltd

Medical Developments International Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.346
  • Today's Change0.00 / 0.00%
  • Shares traded5.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 24 2024 20:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments9.742520
Total Receivables, Net7.078.936.25
Total Inventory8.778.387.11
Prepaid expenses0.570.790.62
Other current assets, total------
Total current assets264334
Property, plant & equipment, net101212
Goodwill, net3.813.813.81
Intangibles, net193537
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets5910192
LIABILITIES
Accounts payable0135.17
Accrued expenses0.640.730.68
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.370.350.35
Other current liabilities, total8.541.154.28
Total current liabilities9.551610
Total long term debt1.922.212.47
Total debt2.292.562.81
Deferred income tax0.02----
Minority interest------
Other liabilities, total1.952.2422
Total liabilities132035
SHAREHOLDERS EQUITY
Common stock10610677
Additional paid-in capital------
Retained earnings (accumulated deficit)(61)(28)(23)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.01(0.07)0.01
Total equity468157
Total liabilities & shareholders' equity5910192
Total common shares outstanding898974
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.